European Archives - Page 1015 of 1049 - European Medical Journal

Continue
EMJ
28 Nov 2014

Infecciones urinarias en grupos de población específicos y polémica en torno al tratamiento de la enfermedad

Resumen de las presentaciones seleccionadas de la cumbre OM Pharma/ViforPharma URO-VAXOM® celebrada en Buenos Aires (Argentina) los días 26 y 27 de abril de 2014
EMJ
28 Nov 2014

Introduction to the Burden of Recurrent Cystitis and Rationale for Prevention

This educational summit, supported by an independent grant from OM/Vifor Pharma, brought together experts in the field of urology and gynaecology…
EMJ
28 Nov 2014

Recurrent Urinary Tract Infections: Can Immunoactive Prophylaxis Improve Disease Management In Healthy Women?

This educational summit, supported by an independent grant from OM/Vifor Pharma, brought together experts in the field of urology and gynaecology from…
EMJ
28 Nov 2014

Urinary Tract Infection in Specific Populations and Controversies in Disease Management

The physiological and anatomical changes associated with pathological and non-pathological conditions, such as pregnancy, can modify both the risk…
EMJ
28 Nov 2014

Infecciones urinarias recurrentes: ¿puede la profilaxis inmunoactiva mejorar el tratamiento de la enfermedad en mujeres sanas?

Resumen de las presentaciones seleccionadas de la cumbre OM Pharma/Vifor Pharma URO-VAXOM® celebrada en Buenos Aires (Argentina) los días 26 y 27…
EMJ
November 2014

EMJ Urology 1 [Suppl 3] 2014

Esta cumbre, de carácter educativo y financiada por una beca independiente de OM/Vifor Pharma, ha reunido a expertos en urología y ginecología…
EMJ
November 2014

EMJ Urology 1 [Suppl 2] 2014

This education summit, supported by an independent grant from OM/Vifor Pharma, brought together experts in the field of urology and gynaecology from…
EMJ
25 Nov 2014

Experts Call for Greater Awareness of Alcohol Related Liver Disease and Liver Cancer

Vienna, 24 November 2014 – United European Gastroenterology (UEG) is supporting the second annual Awareness Week on Alcohol Related Harm (AWARH)
EMJ
24 Nov 2014

High-Dose Interleukin-2 Effective in Metastatic Renal Cell Cancer Pre-Treated with VEGF-Targeted Therapies

Lugano/Geneva, Switzerland, 24 November 2014 – High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated…
24 Nov 2014

Optimising the Patient Journey in Chronic Spontaneous Urticaria

Summary of Presentations from the Novartis-Supported Satellite Symposium, held at the 23rd EADV Congress, Amsterdam, on 9th October 2014